NCT03927404

Brief Summary

The purpose of the study is to evaluate residual limb circulation and skin health associated with the use of a prosthetic vacuum socket. A conventional non-vacuum prosthetic socket will be compared to a vacuum prosthetic socket. The prosthetic suspension plays a pivotal role in an amputee's comfort. It can also significantly impact an amputee's limb health. If the prosthesis is not held securely to the amputee's limb, relative movement between the limb and prosthetic interface can cause bruising, skin irritation and skin breakdown. These poor outcomes are uncomfortable and can lead to much more serious health conditions. A positive solution to creating secure and comfortable suspension is the use of a vacuum suspension socket. The vacuum pressure assists in preventing movement in the socket. The clinical benefits associated with vacuum suspension include volume retention, increased proprioception, secure suspension, and frequently reported observations of wound healing. However, the long term effects of vacuum suspension on circulation remain undetermined or undocumented. This study examines a vacuum suspension system on the health of the residual limb (amputated limb). A vacuum socket creates a vacuum between the rigid prosthetic socket and prosthetic liner which is sealed to the socket. Therefore, vacuum is not directly applied to the skin of the residual limb.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 25, 2019

Completed
10 months until next milestone

Study Start

First participant enrolled

February 12, 2020

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2021

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 6, 2021

Completed
2.7 years until next milestone

Results Posted

Study results publicly available

May 24, 2024

Completed
Last Updated

May 24, 2024

Status Verified

May 1, 2024

Enrollment Period

1.5 years

First QC Date

April 23, 2019

Results QC Date

August 16, 2022

Last Update Submit

May 23, 2024

Conditions

Keywords

Transfemoral AmputeesTranstibial AmputeesProsthesis

Outcome Measures

Primary Outcomes (1)

  • Ratio of Trans-epidermal Water Loss (TEWL) at 16 Weeks After Use

    Trans-epidermal Water Loss in 16 wks. Higher TEWL value represents a worse outcome with loss of skin barrier function. The value reported is the ratio of the TEWL of residual limb over TEWL value of the sound side limb.

    Baseline and 16 Weeks

Secondary Outcomes (2)

  • Change in Hyperspectral Imaging at 16 Wks

    Baseline to16 weeks

  • Ultrasound Measurements at 16 Wks

    16 weeks

Study Arms (1)

Adaptive Vacuum test Prosthesis

EXPERIMENTAL

The experimental socket system uses an active vacuum pump to push air out of the socket. The level of vacuum is controlled by hardware that automatically detects the socket fit based on in-socket motion and adjusts vacuum as needed to eliminate this motion.

Device: Active vacuum test prosthesis

Interventions

The adaptive vacuum prosthesis is sold as a commercial device by the company Willow Wood with suggested U.S. L-Code L5781. The device is designated as a Class 1 Medical Device and 510(K) Exempt. This category is part of a low or moderate risk to patient safety and health. The Prosthetic socket system uses an active vacuum pump to push air out of the socket. The level of vacuum is controlled by hardware that automatically detects the socket fit based on in-socket motion and adjusts vacuum as needed to eliminate this motion.

Also known as: Limb logic system
Adaptive Vacuum test Prosthesis

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ages of 18 and above
  • Unilateral transtibial or transfemoral amputee
  • Ambulate at a K2 level or higher
  • At least 3 months post-amputation per physician discretion
  • Residual limb length greater than 6.5 inches in length
  • Able to follow directions and give informed consent on their own or through Legally Authorized Representative.
  • Must be able to ambulate without assistance. An external assistance device such as cane or walker will be permitted.
  • Adequate arterial blood flow as evidenced by a TcOM \>30mmHg measured within the past 12 months.

You may not qualify if:

  • Conditions that prevent wearing a prosthetic socket,such as existing scab, ulcer, or keloid scar on amputation stump.
  • Cognitive deficits or mental health problems that would limit ability to consent and participate fully in the study protocol
  • Women who are pregnant or who plan to become pregnant in the near future

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IU Health Methodist Hospital

Indianapolis, Indiana, 46202, United States

Location

Related Publications (9)

  • Epstein RA, Heinemann AW, McFarland LV. Quality of life for veterans and servicemembers with major traumatic limb loss from Vietnam and OIF/OEF conflicts. J Rehabil Res Dev. 2010;47(4):373-85. doi: 10.1682/jrrd.2009.03.0023.

    PMID: 20803405BACKGROUND
  • Schultz AE, Baade SP, Kuiken TA. Expert opinions on success factors for upper-limb prostheses. J Rehabil Res Dev. 2007;44(4):483-9. doi: 10.1682/jrrd.2006.08.0087.

    PMID: 18247245BACKGROUND
  • Zachariah SG, Saxena R, Fergason JR, Sanders JE. Shape and volume change in the transtibial residuum over the short term: preliminary investigation of six subjects. J Rehabil Res Dev. 2004 Sep;41(5):683-94. doi: 10.1682/jrrd.2003.10.0153.

    PMID: 15558398BACKGROUND
  • Fernie GR, Holliday PJ. Volume fluctuations in the residual limbs of lower limb amputees. Arch Phys Med Rehabil. 1982 Apr;63(4):162-5.

    PMID: 7082139BACKGROUND
  • Sanders JE, Fatone S. Residual limb volume change: systematic review of measurement and management. J Rehabil Res Dev. 2011;48(8):949-86. doi: 10.1682/jrrd.2010.09.0189.

    PMID: 22068373BACKGROUND
  • Krueger CA, Wenke JC, Ficke JR. Ten years at war: comprehensive analysis of amputation trends. J Trauma Acute Care Surg. 2012 Dec;73(6 Suppl 5):S438-44. doi: 10.1097/TA.0b013e318275469c.

    PMID: 23192067BACKGROUND
  • Ramasamy A, Hill AM, Phillip R, Gibb I, Bull AM, Clasper JC. The modern "deck-slap" injury--calcaneal blast fractures from vehicle explosions. J Trauma. 2011 Dec;71(6):1694-8. doi: 10.1097/TA.0b013e318227a999.

    PMID: 21808204BACKGROUND
  • Bui KM, Raugi GJ, Nguyen VQ, Reiber GE. Skin problems in individuals with lower-limb loss: literature review and proposed classification system. J Rehabil Res Dev. 2009;46(9):1085-90. doi: 10.1682/jrrd.2009.04.0052.

    PMID: 20437314BACKGROUND
  • Harris AM, Althausen PL, Kellam J, Bosse MJ, Castillo R; Lower Extremity Assessment Project (LEAP) Study Group. Complications following limb-threatening lower extremity trauma. J Orthop Trauma. 2009 Jan;23(1):1-6. doi: 10.1097/BOT.0b013e31818e43dd.

    PMID: 19104297BACKGROUND

Results Point of Contact

Title
Dr. Sashwati Roy
Organization
University of Pittsburgh

Study Officials

  • Chandan Sen, PhD

    Indiana University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: This is a 16 weeks longitudinal study where subjects will serve their own control. A baseline measurement will be done prior to start of intervention that will continue for 16 weeks and a final measurement will be taken at the end of 16 weeks.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Vice President of Research

Study Record Dates

First Submitted

April 23, 2019

First Posted

April 25, 2019

Study Start

February 12, 2020

Primary Completion

August 25, 2021

Study Completion

September 6, 2021

Last Updated

May 24, 2024

Results First Posted

May 24, 2024

Record last verified: 2024-05

Locations